Methocarbamol Tablet
Product Images NDC 51655-575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 51655-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 575 20 Master Bottle Label Approval Rev A 08 20)

Label (51655 575 20 Master Bottle Label Approval   Rev A 08 20)
Methocarbamol Tablets USP 750 mg label for oral tablets, containing 20 tablets. The label includes dosage storage instructions, barcode, QR code, and manufacturer information. It indicates the product is by Northwind Health Company, LLC, with a noted NDC of 51655-575-20.*
FDA Label Image

Address (Address)

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of Methocarbamol, showing its molecular connectivity including phenyl ring, methoxy group, hydroxy group, and amide functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.